TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer.

Evan Y Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.